Science
The right timing of treatment keeps resistant cells in check, yeast experiments suggest
Publication: Phys.org - latest science and technology news stories
Author: Not available in collected metadata
Source published: 28/09/2026, 14:40:05 UTC
Briefing created: 28/09/2026, 14:41:11 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 28/09/2026, 14:40:24 UTC.
Briefings
A recent study suggests that the precise timing of treatment cycles can prevent the development of resistance in both cancer and antibiotic therapy. Yeast experiments indicate that targeted timing may curb the spread of resistance, offering a potential new approach to modern therapeutic strategies.
Key points
- Yeast experiments suggest that targeted timing of treatment cycles can curb the spread of resistance in both cancer and antibiotic therapy.
- The study indicates that the right timing of treatment keeps resistant cells in check, potentially preventing resistance from developing.
Context and limitations
Evidence is limited to yeast experiments and does not include human clinical trials or long-term data.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 28/09/2026, 14:41:11 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeiewgn3lh5ippmmpjdpl6i34gejpws7duuf7niz6ih4igfpdyw2rne